<DOC>
	<DOCNO>NCT01330238</DOCNO>
	<brief_summary>Modic change associate low back pain ( LBP ) clinical general population-based sample . Type I change regard likely painful type II change . Several study suggest type I change inflammatory nature .</brief_summary>
	<brief_title>The Efficacy Zoledronic Acid Modic Changes-related Low Back Pain ( LBP )</brief_title>
	<detailed_description>So far , treatment exists LBP due Modic change . Bisphosphonates could effective specific low back disorder two mechanism : 1 ) could consolidate vertebral body thereby improve tolerance mechanical load 2 ) could diminish inflammation observe recently case ibandronate experimental model .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>age 18 year old low back pain 3 month Modic type I II change lumbar magnetic resonance image Intensity low back pain least 6 10cm VAS Oswestry disability score least 30 % premenopausal female patient possibility pregnancy patient calculate creatinine clearance le 40 ml/min patient hypocalcemia patient know hypersensitivity zoledronic acid bisphosphonates ingredient infusional product patient red flag symptom patient nerve root impingement patient willingness early retirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Low back pain</keyword>
	<keyword>Modic change</keyword>
	<keyword>Vertebral endplate signal change</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Zoledronic acid</keyword>
	<keyword>Bisphosphonates</keyword>
	<keyword>RCT</keyword>
</DOC>